These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8626086)

  • 1. Precision of ultrasonic estimates of choroidal melanoma regression.
    Rask R; Jensen PK
    Graefes Arch Clin Exp Ophthalmol; 1995 Dec; 233(12):777-82. PubMed ID: 8626086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic three-dimensional scanning for determination of intraocular tumour volume.
    Jensen PK
    Acta Ophthalmol Suppl (1985); 1992; (204):23-5. PubMed ID: 1332389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model.
    Rashid M; Heikkonen J; Singh AD; Kivelä TT
    Ophthalmology; 2018 May; 125(5):747-754. PubMed ID: 29499831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echographic evaluation of choroidal melanomas treated with ruthenium-106 plaques: the treatment failures.
    Perri P; Police G; Pastena B; Ravalli L; Grande L; Rossi A
    Ophthalmologica; 1998; 212 Suppl 1():33-6. PubMed ID: 9730745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choroidal metastasis of cutaneous malignant melanoma treated by ruthenium-106 plaque irradiation.
    Anteby I; Axer-Siegel R; Pe'er J
    Ann Ophthalmol; 1993 Sep; 25(9):339-41. PubMed ID: 8297070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for confirmation of positioning of ruthenium plaques by postoperative B-scan ultrasonography.
    Anteby II; Pe'er J
    Ophthalmic Surg Lasers; 1996 Dec; 27(12):1024-9. PubMed ID: 8976522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional ultrasonography of choroidal melanoma: localization of radioactive eye plaques.
    Finger PT; Romero JM; Rosen RB; Iezzi R; Emery R; Berson A
    Arch Ophthalmol; 1998 Mar; 116(3):305-12. PubMed ID: 9514483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
    Pe'er J; Averbukh E; Frenkel S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment control of choroidal melanomas--the role of B-scan and Doppler-technique.
    Guthoff R; Winkler P; Helmke K; Berger R
    Acta Ophthalmol Suppl (1985); 1992; (204):59-61. PubMed ID: 1332396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative color Doppler imaging in untreated and irradiated choroidal melanoma.
    Wolff-Kormann PG; Kormann BA; Riedel KG; Hasenfratz GC; Stefani FH; Spengel FA; Lund OE
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1928-33. PubMed ID: 1374744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of contact beta-irradiation of choroidal melanomas.
    Damjanovich J; Berta A; Vezendi L
    Acta Chir Hung; 1997; 36(1-4):67-8. PubMed ID: 9408291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
    Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
    Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early ultrasonographic tumor regression after linear accelerator stereotactic fractionated photon radiotherapy of choroidal melanoma as a predictor for metastatic spread.
    Mitsch C; Zehetmayer M; Gleiss A; Georg D; Dieckmann K; Pötter R; Sayegh R; Schmidt-Erfurth U; Dunavoelgyi R
    Radiother Oncol; 2018 Jun; 127(3):385-391. PubMed ID: 29747872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonographic, three-dimensional scanning for determination of intraocular tumor volume.
    Jensen PK; Hansen MK
    Acta Ophthalmol (Copenh); 1991 Apr; 69(2):178-86. PubMed ID: 1872136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma.
    Chang MY; Kamrava M; Demanes DJ; Leu M; Agazaryan N; Lamb J; Moral JN; Almanzor R; McCannel TA
    Ophthalmology; 2012 May; 119(5):1073-7. PubMed ID: 22297030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal melanoma suspect. Conservative treatment and evolution. Case report.
    Zemba M; Malciolu RA
    Rom J Ophthalmol; 2016; 60(4):264-269. PubMed ID: 29450360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy].
    Bogdali A; Romanowska-Dixon B
    Klin Oczna; 2015; 117(3):169-72. PubMed ID: 26999940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonographic follow-up of patients with choroidal melanoma following conservative treatment.
    Ravozzoni L; Mosci C; Polizzi A; Schenome M; Soldati MR; Buono C
    Ophthalmologica; 1998; 212 Suppl 1():77-8. PubMed ID: 9730759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.